The emerging practice of vaping 5MeO dimethyltryptamine in Canada presents significant risks and challenging statutory issues. Currently, 5meo dimethyltryptamine remains a Schedule Number One substance under this Controlled Drugs and Substances Act, rendering its ownership and sale illegal. While ingestion delivers the compound rapidly, it furtherm